Skip to main content
Signal8

Malzahn Craig

SEC insider (Form 3/4/5 filer). CIK 0002062007. Chief Technology Officer at REGENXBIO Inc. (RGNX). 4 reported Form 4/5 transactions since Sep 2024; latest on Sep 1, 2026. Located in ROCKVILLE, MD.

Companies Malzahn Craig has filed insider reports for

  • REGENXBIO Inc. (RGNX): Officer, Chief Technology Officer
Malzahn Craig profile photo

Malzahn Craig

CIK: 0002062007

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)3 (75.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

REGENXBIO Inc. logo
RGNX

REGENXBIO Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • REGENXBIO Inc. logo
    RGNX

    REGENXBIO Inc.

    Sep 1, 2026
    Tax Payment
    Direct
    234 shares at avg. $9.32$2K
  • REGENXBIO Inc. logo
    RGNX

    REGENXBIO Inc.

    Jan 6, 2026
    Award
    Direct
    65.8K shares-
  • REGENXBIO Inc. logo
    RGNX

    REGENXBIO Inc.

    Jan 2, 2026
    Tax Payment
    Direct
    1.2K shares at avg. $14.40$18K
  • REGENXBIO Inc. logo
    RGNX

    REGENXBIO Inc.

    Sep 1, 2025
    Tax Payment
    Direct
    234 shares at avg. $8.93$2K

1-4 of 4